Clary Clish

Clary Clish directs one of the largest metabolomics platforms in the world at the Broad Institute, generating cancer metabolomics data for major epidemiological cohorts and clinical trials. His platform operations have profiled metabolites in hundreds of thousands of samples, enabling discovery of metabolic biomarkers for cancer risk, early detection, and treatment response. His rigorous quality control procedures and standardized analysis pipelines have established the reliability standards for large-scale clinical metabolomics studies.